// App-Quantinova.ai

e21546 : Using precision microbiome profiling to develop a biomarker for immune checkpoint inhibitor response and a novel therapeutic.

Researchers

Presenter

  • Mat Robinson

Principal Investigators

  • Kevin Vervier

  • Amy Popple

  • Simon Harris

  • Robyne Hudson

  • David Adams

  • Roy Rabbie

  • Doreen Milne

  • Catherine Booth

  • Sarah Joanne Welsh

  • David Bruce

  • Philippa Gail Corrie

  • Trevor Lawley

Medical Centers

  • MedImmune, Cambridge, United Kingdom

  • Microbiotica, Cambridge, United Kingdom

  • Microbiotica, Cambridge, United Kingdom

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Cambridge Cancer Centre, Cambridge, United Kingdom

  • Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved